Human papillomavirus (HPV) infections result in a substantial burden of disease globally. HPV causes cancers in both men and women, particularly cancer of the cervix (in females), other anogenital cancers and certain cancers of the mouth and throat (in both males and females). In 2007, Australia became one of the first countries to fund and implement a National HPV Vaccination Programme which has had a significant impact on the incidence of HPV and associated disease.
This next NCIRS seminar/webinar will reflect on the success of the HPV vaccination program in Australia and explore opportunities for the future. Hear from some of Australia’s experts in the field.